On May 24, 2019, BioCanRx met with members of its Cancer Stakeholder Alliance at the Ontario Institute for Cancer Research headquarters in downtown Toronto. The primary goals of the meeting were to discuss Cycle Two Joint Action Plan priorities and to receive helpful feedback from various non-profit partners regarding patient experience and interaction with BioCanRx… Read more »
Category: News
Summit for Cancer Immunotherapy coming in October! Submit Your Abstract!
Abstract submission is now open for the Summit for Cancer Immunotherapy. The 2019 Summit4CI takes place October 20-23, 2019, in Victoria, BC. Up to 100 HQP will be selected for travel awards to attend Summit4CI. The awards will be adjudicated based on your abstract submission. Abstracts will be selected for poster presentations and, in… Read more »
And … presto!
By: Heather Blumenthal It’s a bit like a magic trick – put a tumour sample into a box, wave your magic wand above it and presto – out come the immune cells most likely to attack the tumour successfully. OK, so it’s not that simple. Or that magical. But it does represent a… Read more »
Introducing the winners of BioCanRx’s 2019 Summer Studentships
BioCanRx is pleased to introduce you to the 15 undergraduate students chosen from across Canada through a competitive application process to be part of our Summer Studentship Program. The program’s goal is to inspire the next generation of highly qualified personnel to pursue research in cancer immuno-oncology. Undergraduate and college students receive funding to conduct… Read more »
BioCanRx Cycle II LOI Call
BioCanRx, Canada’s Immunotherapy Network, is pleased to announce its 2019 Call for Letters of Intent. Selected Letters of Intent will be featured in the Scientific Program of our Cycle II application going forward for review in July 2019 to the federal government’s Networks of Centres of Excellence (NCE) Program. Building on previous BioCanRx… Read more »
Diving deep into the abdominal cavity
By: Heather Blumenthal Here’s a mental picture for you – your liver floating up around your lungs or your gall bladder sinking down to your knees. It’s not a pretty picture and, fortunately, it doesn’t happen, thanks to your peritoneum – a lining of the abdominal cavity that holds all your abdominal organs in… Read more »
BioCanRx Lab Exchange at the Alberta Cell Therapy Manufacturing Facility
Blood and bone marrow transplants can be used to treat blood cancers such as leukemia. The transplant can provide a cure when the donor immune cells attack and kill leukemia cells. Unfortunately, the donor cells often also attack the patient’s own tissue, causing serious short- and long-term consequences. To prevent these negative immune responses without… Read more »
John Bell Wins Inaugural ESGCT Public and Patient Engagement Award
BioCanRx is pleased to announce that Scientific Director Dr. John Bell, of The Ottawa Hospital, has won the the inaugural European Society for Gene and Cell Therapy (ESGCT) Public and Patient Engagement Award. This is the first-ever honour of its kind offered by ESGCT. The award recognizes outstanding contribution to, and participation in, public… Read more »
Giving melanoma the one-two punch
By: Heather Blumenthal In most cases, skin cancers are not that big a deal – easy to treat and rarely causing long-term problems. These basal-cell and squamous-cell skin cancers account for 95% of all skin cancers diagnosed in Canada. But that other 5% is a different matter entirely. Melanoma is a much more serious… Read more »
World Cancer Day 2019: A Message from Dr. John Bell, Scientific Director and Dr. Stéphanie Michaud, President & CEO BioCanRx
9.6 million people in the world die from cancer every year. This number is predicted to almost double by 2030, according to the Union for International Cancer Control. Here in Canada, the Canadian Cancer Society reports “an estimated 206,200 new cases of cancer and 80,800 deaths from cancer occurred in Canada in 2017. (The number… Read more »
